PPARgamma agonists promote the resolution of myelofibrosis in preclinical models.
| Description | |
| Date | |
| Auteurs | Lambert J, Saliba J, Calderon C, Sii-Felice K, SalmaM, Edmond V, Alvarez JC, Delord M, Marty C, Plo I, Kiladjian JJ, Soler E, Vainchenker W, Villeval JL, Rousselot P and Prost S
|
| Revue | |
| Année | 2021 |
| Service | |
| Institut | |
| Laboratoire | |
| Résumé | |
| Date de création | 01/06/2021 |